Calidi Biotherapeutics stock was up 171.84% in pre-market trading on Wednesday, following a 39.47% rally yesterday. However, ...

Calidi Biotherapeutics Inc. CLDI stock surged by 39.47% in the after-hours trading session on Tuesday. The stock price ...

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a ...

Ladenburg Thalmann & Co, Inc. is acting as the exclusive placement agent for the offering.

In a stark reflection of the challenges facing the market, shares of First Light Acquisition Group (CLDI) have tumbled to a 52-week low, touching down at a mere $0.6, with market capitalization ...

CLDI has purchased new properties on South 32nd Street to create a connected campus of six buildings across four lots. Two new structures will soon be constructed at the location, with ...

A high-level overview of Calidi Biotherapeutics, Inc. (CLDI) stock. View (CLDI) real-time stock price, chart, news, analysis, analyst reviews and more.